Tesla Inc. (NASDAQ: TSLA) is increasing the price of the "Full Self-Driving" feature in its electric vehicles by $1,000 starting July 1, Chief Executive Officer Elon Musk said Monday.> Tesla Full Self-Driving option cost rises by ~$1000 worldwide on July 1st. Order a Tesla online in less than 2 minutes at https://t.co/qJm9uPBCX5> > -- Elon Musk (@elonmusk) May 18, 2020The driver-assistance option currently costs $7,000. According to Musk, the price of the feature will "continue to rise" going forward. When the autonomous driving feature nears to "full capability" and receives regulatory approval, the price is "probably somewhere in excess of $100,000," Musk noted. The billionaire entrepreneur suggested last month the price of the full self-driving feature will "probably" increase on July 1.> Yeah, probably July 1st> > -- Elon Musk (@elonmusk) April 3, 2020Musk has been lately embroiled in a public feud with Alameda County officials as Tesla scrambled to restart...
(Bloomberg) -- Moderna Inc. plans to raise as much as $1.3 billion through a sale of shares to fund manufacturing of a coronavirus vaccine seen as one of the frontrunners in the race for immunization against the widening pandemic.The U.S. biotechnology firm will sell 17.6 million shares priced at $76 a piece, according to a statement Tuesday. The price represents a 5% discount to Monday’s closing price.Morgan Stanley is the sole book-running manager for the offering that allows underwriters to buy an additional 2.64 million shares, the statement said. Bloomberg reported the share sale plan earlier.Shares jumped 20% on Monday after the company revealed positive early results from its experimental vaccine for Covid-19, capping off a 309% rally this year.Moderna’s vaccine is seen as one of the most promising candidates for immunization against the pathogen that has sickened over 4.8 million people worldwide and killed over 318,000 since it first emerged...
(Bloomberg) -- Moderna Inc. plans to raise as much as $1.3 billion through sale of shares to fund manufacturing of a coronavirus vaccine that can help curb the pandemic and allow governments to ease lockdowns.The U.S. biotechnology firm will sell 17.6 million shares priced at $76 a piece, according to a statement. The price represents a 5% discount to Monday’s closing prices. Morgan Stanley is the sole book-running manager for the offering that allows underwriters to buy an additional 2.64 million shares, the drugmaker said in the statement. Bloomberg reported the share sale earlier. Shares jumped 20% on Monday after the company revealed positive early results from its experimental vaccine for Covid-19, capping off a 309% rally this year.Moderna has emerged as one of the front-runners in the global race to make vaccines against the deadly pathogen that has sickened over 4.8 million people worldwide and killed over 318,000 since it...
The move is part of a longer-term bet that CEO Ed Bastian highlighted to investors last month: that consumers' perceptions of safety will be instrumental in reviving more routine travel, and that they will be willing to pay a premium for comfort. Specific details could still change, the people said on condition of anonymity, citing the uncertain timing of a recovery from the coronavirus crisis that has decimated air travel demand. Delta has publicly said that it will limit first class seating capacity at 50% and main cabin at 60% through June 30, and earlier announced that it was resuming some flights next month....
(Bloomberg) -- Nasdaq is set to unveil new rules for initial public offerings including tougher accounting standards that will make it more difficult for some Chinese companies to list on the exchange.Under the new rules, companies from countries, including China, will need to raise at least $25 million in their IPO or alternatively at least a quarter of their post-listing market capitalization, according to Nasdaq filings seen by Bloomberg News. Many IPOs by Chinese firms are smaller than that and are thinly-traded as shares are held by a small group of insiders.“The exchange believes that the proposal to require a restrictive market company conducting an IPO to offer a minimum amount of securities in the U.S. to public holders in a firm commitment offering will provide greater support for the company’s price,” Nasdaq said in the filing.While the rules do not single out Chinese companies, the proposed changes include applying additional...
